Document is current
Any future updates will be listed below
-
Authors
Zemlok, Sarah Kamsiah
Yu, JiaDe
- License Information
-
More Information
Article History
Accepted: 13 September 2024
First Online: 25 September 2024
Declarations
:
: SZ receives quarterly royalties from Sanofi for patent licensing of the drug belumosudil. JY has served as a consultant/advisory board/investigator for the following: Abbvie, Arcutis, Astria, Dermavant, iRhythm, Leo, Lilly, National Eczema Association, O’Glacee, Pfizer, Sanofi, Smartpractice, Sol-Gel. He also receives honorarium from UptoDate.
